Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Alpha Thalassemia Major

NCT02986698 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02986698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02986698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Alpha Thalassemia Major
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Terminated
Start date
October 5, 2017
Completion date
December 31, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

a-thalassemia, alpha thalassemia major, alpha; thalassemia, fetal anemia, fetal hydrops, hemoglobinopathies, hemoglobinopathy; with thalassemia, thalassemia alpha, thalassemia major